Caspase-3 activity was increased at 24, 48, and 72 h in both colon cancer (SW480 and SW620) cells treated with MS13 at EC50 and 2XEC50 compared to the untreated cells (Figure 7). This evidence concerns the gene CASP3 and colonic neoplasm.